E-WE Thrombin

Stephen Hanson, PhD

E-WE thrombin is indicated for a one-time use, temporal infusion treatment of suspected or verified stroke or heart attack in human patients, preferably as an emergency drug given in the ambulance or by the attending physician. Aronora, a biopharmaceutical startup based on the West Coast, licensed the technology from Emory in 2013.